Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.88%
1,100.61
-9.73
-0.88%
—1,110.341,110.371,117.241,097.84——
SIXC
Communications
SIXC
Communications
SIXC
-1.33%
612.30
-8.24
-1.33%
—620.54620.54622.67611.42——
SIXE
Energy
SIXE
Energy
SIXE
+1.40%
1,175.46
+16.26
+1.40%
—1,159.201,160.591,177.621,156.21——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.39%
1,729.12
-24.32
-1.39%
—1,753.441,749.081,762.011,724.74——
SIXM
Financials
SIXM
Financials
SIXM
-0.63%
644.73
-4.07
-0.63%
—648.80649.58655.73643.68——
SIXR
Staples
SIXR
Staples
SIXR
-0.65%
827.09
-5.40
-0.65%
—832.49832.07833.09826.15——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-1.98%
214.82
-4.34
-1.98%
—219.16219.16219.19214.82——
SIXT
Technology
SIXT
Technology
SIXT
+0.06%
3,115.17
+1.81
+0.06%
—3,113.363,120.793,143.643,105.16——
SIXU
Utilities
SIXU
Utilities
SIXU
-1.75%
910.43
-16.24
-1.75%
—926.67927.99930.54910.08——
SIXV
Health care
SIXV
Health care
SIXV
-1.01%
1,474.50
-15.11
-1.01%
—1,489.611,499.051,499.051,474.35——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,405.87
-17.39
-0.72%
—2,423.262,438.162,443.462,399.83——
NZM2:ETR
Novozymes A/S
€50.80
-0.74%
(-0.38) 1D
Apr 21, 5:35:35 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for NZM2...
Open
€51.32
High
€51.32
Low
€50.80
Mkt. cap
158.30B
Avg. vol.
304.00
Volume
39.00
52-wk high
€57.24
52-wk low
€46.74
No. of employees
11K
News stories
From sources across the web
Profile
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024. Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
About Novozymes A/S
CEOEster Baiget
Employees11.1K
Founded2000
Headquarters-
SectorSpeciality chemicals
Websitenovonesis.com
Last report
Feb 25, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
3.36/ (7.15 est.)DKK
-52.95%miss
Revenue / Estimate
7.45B/ (7.73B est.)DKK
-3.68%miss
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in DKK
Loading Previous Earnings...
Income statement
Revenue
Net income
Revenue
Cost of goods sold
Cost of revenue
Research and development expenses
Total research and development expenses
Selling, general, and admin expenses
Operating expense
Total operating expenses
Operating income
Other non operating income
EBT including unusual items
EBT excluding unusual items
Income tax expense
Effective tax rate
Other operating expenses
Net income
Net profit margin
Earnings per share
Interest and investment income
Interest expense
Net interest expenses
Depreciation and amortization charges
EBITDA
Gain or loss from assets sale
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer